Reproductive System Neoplasm, Female - Uterine Cancer

NCT03914612

Clinical Trial Information


Trial Number: NCT03914612 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Study ID:
NRG-GY018
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT00954174

Clinical Trial Information


Trial Number: NCT00954174 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Miscellaneous
  • Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus, Fallopian Tube, Peritoneum or Ovary
Study ID:
GOG-0261
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT00954174-D2 This dataset contains quality of life (QOL) data from trial NCT00954174 presented in 35007153. NCT00954174-D1 contains patient characteristics, outcome data, and adverse event data.
NCT00954174-D1 This dataset contains the data for the treatment comparison between Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in trial NCT00954174. NCT00954174-D2 contains quality-of-life data.

NCT00807768

Clinical Trial Information


Trial Number: NCT00807768 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk, Early Stage Endometrial Carcinoma
Study ID:
GOG-0249
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT00063999

Clinical Trial Information


Trial Number: NCT00063999 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF versus Carboplatin/Paclitaxel in Patients with Stage III & IV or Recurrent Endometrial Cancer
Study ID:
GOG-0209
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT00080776

Clinical Trial Information


Trial Number: NCT00080776 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk, Early Stage Endometrial Carcinoma
Study ID:
GOG 249
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT00942357

Clinical Trial Information


Trial Number: NCT00942357 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma
Study ID:
GOG-0258
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT00006011

Clinical Trial Information


Trial Number: NCT00006011 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Randomized Phase III Study of Tumor Volume Directed Pelvic Plus or Minus Para-Aortic Irradiation Followed by Cisplatin and Doxorubicin or Cisplatin, Doxorubicin and Paclitaxel for Advanced Endometrial Carcinoma
Study ID:
GOG-0184
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

NCT01533207

Clinical Trial Information


Trial Number: NCT01533207 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Phase III Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) Versus Observation for Uterus-Limited, High-Grade Uterine Leiomyosarcoma
Study ID:
GOG-0277
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT01533207-D2 This dataset contains AE data from PubMed 30289732.
NCT01533207-D1 This dataset will allow users to reproduce the treatment comparison between Adjuvant Gemcitabine Plus Docetaxel Followed by
Doxorubicin and Observation from PubMed 30289732.

NCT01672892

Clinical Trial Information


Trial Number: NCT01672892 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Cervical Cancer
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Study ID:
RTOG-1203
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT01672892-D1 This dataset contains patient-reported acute toxicity and health-related quality of life (QOL) data from trial NCT01672892 to reproduce the results in PubMed ID=29989857.

NCT01012297

Clinical Trial Information


Trial Number: NCT01012297 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Randomized Phase III Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Bevacizumab (NSC #704865) Versus Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Placebo in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus
Study ID:
GOG-0250
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT01012297-D1 This dataset will allow users to reproduce the treatment comparison between Gemcitabine Plus Docetaxel Plus Bevacizumab and Gemcitabine Plus Docetaxel Plus Placebo
Subscribe to Reproductive System Neoplasm, Female - Uterine Cancer

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®